ADVERTISEMENT
ADVERTISEMENT
Product Liability Group Of The Year: Covington
Law360 (December 14, 2020, 11:23 PM EST) Securing a precedential win for Boehringer Ingelheim Pharmaceuticals Inc. in litigation over its blood thinner Pradaxa and ending nearly 20 years of lawsuits against Hoffmann-La Roche AG alleging that its acne medication Accutane causes bowel disease have earned Covington & Burling a spot as one of Law360 s 2020 Product Liability Practice Groups of the Year.
Michael Imbroscio, co-chair of the product liability group, told Law360 that the group, which includes about 30 lawyers, is a key component of the firm and a focused subset of its broader litigation practice.
Jardiance® associated with a total cost of care savings of more than 20%, according to results from an outcomes-based agreement between Boehringer Ingelheim and Highmark
Share Article
Highmark and Boehringer Ingelheim announced positive results from their outcomes-based agreement, which showed that adults with type 2 diabetes and known cardiovascular disease who took Jardiance® (empagliflozin) had a lower annual total cost of care compared with those prescribed other branded or generic anti-hyperglycemic medications. Patients on Jardiance demonstrated a reduction in medical costs of over 30%. Factoring in both medical and pharmacy costs, the overall total cost of care reduction was more than 20% for patients on Jardiance.